February 29, 2008

MODA Technology Partners and Applied Biosystems Team With XOMA for Deployment of SQL*LIMS Micro/EM(TM) at Berkeley, CA Manufacturing Facilities

MODA Technology Partners (MODA), a software company that provides mobile data acquisition solutions to the pharmaceutical manufacturing industry, today announced that XOMA Ltd. (XOMA), has deployed SQL*LIMS Micro/EM™ to automate environmental and utility monitoring and processes at their biologics manufacturing facilities in Berkeley, CA.

XOMA, a leader in the discovery and development of antibody therapeutics, has extensive experience manufacturing biologics for its proprietary and partnered product programs. XOMA's quality and operational infrastructure enables the manufacture of product candidates through every phase of product development in compliance with cGMP using mammalian and microbial systems. Ric Reordan, XOMA's Manager of Microbiology, states that "Environmental and utility monitoring are a critical part of our QC program. As part of our manufacturing activities, we are required to provide a contaminant free environment for the production of a wide range of therapeutic products. With SQL*LIMS Micro/EM, we have transformed our environmental and utility monitoring program to a paperless operation. Improvements in productivity and compliance enable my team to focus on high value science-based activity rather than administrative paperwork. And ultimately this enhances XOMA's manufacturing operations."

Applied Biosystems has partnered with MODA Technology Partners to expand the SQL*LIMS® product line with SQL*LIMS Micro/EM™, a revolutionary solution combining paperless, mobile data acquisition with unparalleled data visualization and analysis capabilities. Frank Bernard, XOMA's Senior IT Manager explains, "The SQL*LIMS Micro/EM package enabled us to achieve certain efficiencies. We were able to go into production within four months versus an alternative of eighteen months for a solution requiring customization. Support and administration are greatly simplified with a single, unified platform for QA and QC users. And our user community loves the functionality and efficiencies gained in their processes."

"We are very excited to extend our SQL*LIMS implementation at XOMA with SQL*LIMS Micro/EM," states Peter Boogaard, Director of LIMS Product Management and LIMS Global Marketing at Applied Biosystems. "Our partnership with MODA enables us to better serve our client needs with an integrated solution for quality assurance and quality control. We are very pleased that XOMA is already benefiting from this solution."

David Lipson, MODA's CEO and Chairman, stated, "We are proud that MODA products power the SQL*LIMS Micro/EM solution and we are confident that this solution will help ensure that a first class environmental monitoring program is maintained for all of XOMA's extensive manufacturing processes."

About XOMA

XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies. The Company's expanding pipeline includes XOMA 052, an anti-IL-1 beta antibody, and XOMA 629, a synthetic peptide compound derived from bactericidal/permeability-increasing protein.

XOMA's proprietary development pipeline is primarily funded by multiple revenue streams resulting from the licensing of its antibody technologies, product royalties, development collaborations, and biodefense contracts. XOMA's technologies and experienced team have contributed to the success of marketed antibody products, including RAPTIVA® (efalizumab) for chronic moderate to severe plaque psoriasis and LUCENTIS® (ranibizumab injection) for wet age-related macular degeneration.

The Company has a premier antibody discovery and development platform that incorporates leading antibody phage display libraries and XOMA's proprietary Human Engineering™ and bacterial cell expression (BCE) technologies. BCE is a key breakthrough biotechnology for the discovery and manufacturing of antibodies and other proteins. As a result, more than 50 pharmaceutical and biotechnology companies have signed BCE licenses.

In addition to developing its own products, XOMA develops products for premier pharmaceutical companies including Novartis AG, Schering-Plough Research Institute and Takeda Pharmaceutical Company Limited. XOMA has a fully integrated product development infrastructure, extending from pre-clinical science to product launch, and a team of 300 employees at its Berkeley location. For more information, please visit http://www.xoma.com.

About MODA Technology Partners

MODA Technology Partners (MODA) is a commercial software company whose primary focus is addressing the growing need for effective automation and efficient regulatory compliance within pharmaceutical manufacturing. MODA's solution leverages mobile computing technology to help their clients increase operational efficiency, improve quality and reduce manufacturing costs. Additional information is available at www.modatp.com.